Visium Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-177,915
Closed -$13.3M 434
2016
Q1
$13.3M Sell
177,915
-122,512
-41% -$9.23M 0.23% 112
2015
Q4
$23.1M Buy
+300,427
New +$22.6M 0.35% 56
2015
Q3
Sell
-39,500
Closed -$2.93M 1079
2015
Q2
$2.93M Sell
39,500
-529,579
-93% -$40.5M 0.04% 374
2015
Q1
$44.4M Buy
569,079
+10,437
+2% +$791K 0.65% 22
2014
Q4
$40.3M Sell
558,642
-40,988
-7% -$2.85M 0.57% 30
2014
Q3
$37.1M Buy
599,630
+587,040
+4,663% +$37.3M 0.55% 29
2014
Q2
$803K Sell
12,590
-339,810
-96% -$20.6M 0.01% 582
2014
Q1
$21.7M Buy
352,400
+181,192
+106% +$10.6M 0.35% 59
2013
Q4
$9.83M Sell
171,208
-55,419
-24% -$3.14M 0.19% 105
2013
Q3
$12.1M Buy
226,627
+211,615
+1,410% +$11.4M 0.27% 70
2013
Q2
$773K Buy
+15,012
New +$742K 0.02% 398

Other funds holding MDT

Visium Asset Management's MDT Position: Q2 2016 in Review

Visium Asset Management sold out of Medtronic (MDT) in Q2 2016, closing a stake of 177,915 shares — an estimated $13.3M sold.

Visium Asset Management first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $44.4M in Q1 2015. 1,263 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

  • Visium Asset Management reported no remaining Medtronic position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 177,915 Medtronic shares in Q2 2016, an estimated $13.3M.
  • Visium Asset Management first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Visium Asset Management's Medtronic position peaked at $44.4M in Q1 2015.
  • 1,263 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.